Electronic Drug Delivery Systems Market by Indication (Cardiovascular Disease, Diabetes, Multiple Sclerosis, Asthma & COPD), by Type (Autoinjectors, Injection Pens, Electronic Wearable Infusion Pump, Electronic Inhalers) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: May 28, 2019
Clear
SKU: GMS2035 Category:

The market for electronic drug delivery systems is predicted to hit USD 11.83 billion by 2024, growing over the forecast period at a CAGR of 8.62%. A key factor driving market growth is the high prevalence of target diseases. In addition, a favorable reimbursement scenario will also fuel market growth in major markets and technological advances in digital drug delivery systems.

Electronic Drug Delivery Systems Market by Indication (Cardiovascular Disease, Diabetes, Multiple Sclerosis, Asthma & COPD), by Type (Autoinjectors, Injection Pens, Electronic Wearable Infusion Pump, Electronic Inhalers) - 2019 to 2024 1

Electronic Drug Delivery Systems Market by Indication (Cardiovascular Disease, Diabetes, Multiple Sclerosis, Asthma & COPD), by Type (Autoinjectors, Injection Pens, Electronic Wearable Infusion Pump, Electronic Inhalers) - 2019 to 2024 2

Electronic Drug Delivery Systems Market by Indication (Cardiovascular Disease, Diabetes, Multiple Sclerosis, Asthma & COPD), by Type (Autoinjectors, Injection Pens, Electronic Wearable Infusion Pump, Electronic Inhalers) - 2019 to 2024 3

Electronic Drug Delivery Systems Market by Indication (Cardiovascular Disease, Diabetes, Multiple Sclerosis, Asthma & COPD), by Type (Autoinjectors, Injection Pens, Electronic Wearable Infusion Pump, Electronic Inhalers) - 2019 to 2024 4

Electronic Drug Delivery Systems Market by Indication (Cardiovascular Disease, Diabetes, Multiple Sclerosis, Asthma & COPD), by Type (Autoinjectors, Injection Pens, Electronic Wearable Infusion Pump, Electronic Inhalers) - 2019 to 2024 5

Electronic Drug Delivery Systems Market by Indication (Cardiovascular Disease, Diabetes, Multiple Sclerosis, Asthma & COPD), by Type (Autoinjectors, Injection Pens, Electronic Wearable Infusion Pump, Electronic Inhalers) - 2019 to 2024 6

Electronic Drug Delivery Systems Market by Indication (Cardiovascular Disease, Diabetes, Multiple Sclerosis, Asthma & COPD), by Type (Autoinjectors, Injection Pens, Electronic Wearable Infusion Pump, Electronic Inhalers) - 2019 to 2024 7

Electronic Drug Delivery Systems Market by Indication (Cardiovascular Disease, Diabetes, Multiple Sclerosis, Asthma & COPD), by Type (Autoinjectors, Injection Pens, Electronic Wearable Infusion Pump, Electronic Inhalers) - 2019 to 2024 8

1 Overview
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Electronic Drug Delivery Systems Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Electronic Drug Delivery Systems Market – By Type (Market Size – & million/billion)
8.1 Electronic Wearable Infusion Pumps
8.2 Electronic Autoinjectors
8.3 Electronic Injection Pens
8.4 Electronic Inhalers

9 Global Electronic Drug Delivery Systems Market – By Indication
9.1 Diabetes
9.2 Multiple Sclerosis
9.3 Cardiovascular Disease
9.4 Asthma & COPD
9.5 Other

10 Global Electronic Drug Delivery Systems Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Electronic Drug Delivery Systems Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Electronic Drug Delivery Systems Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Merck Group
12.3 United Therapeutics Corporation
12.4 Medtronic PLC
12.5 Bayer AG
12.6 Insulet Corporation
12.7 Companion Medical
12.8 Novo Nordisk
12.9 F.Hoffmann-La Roche, Ltd.
12.10 Tandem Diabetes Care, Inc.
12.11 Astrazeneca PLC
12.12 Company 11 & more

13 Global Electronic Drug Delivery Systems Market – Appendix
13.1 Sources
13.2 Abbreviations